Number 3: Part 2 of our series diving into the Association for Accessible Medicines' (AAM) latest report discusses that while generics and biosimilars saved $445 billion in 2023, their potential is ...

Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.

UPMC said wants to make access to care outside of the emergency room more convenient and less costly, especially for ...

UPMC is expanding its footprint across the region. The health care giant is taking over the operations of several MedExpress ...

The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin.

Texas Attorney General Ken Paxton's office said on Thursday it had sued insulin makers Eli Lilly, Novo Nordisk and Sanofi.

Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31, 2024, and will host ...

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...

Bloomfield-based The Cigna Group, which employs 70,000 people, said given the different job functions within the company, ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...

The FDA approved a new strength of a trastuzumab biosimilar; UnitedHealth will remove reference adalimumab from some ...

News Briefs - House Committee Approves Telehealth Modernization Act of 2024 - A House committee voted to advance a bill that ...